About

Hereditary angioedema causes unpredictable, disabling episodes of severe swelling in the body's soft tissues. Lonvoguran ziclomeran is a one-time treatment that uses CRISPR gene editing inside liver cells to permanently alter the KLKB1 gene. This could potentially address the genetic root of the disease and reduce or eliminate future swelling attacks.